ONCT - Oncternal Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ONCT (1260990)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
5 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-09-01
ONCTCarter Michael GDirP - Purchase$2.10+71,42971,947>999%+$150,001
D
2020-07-21
ONCTKisner Daniel LDirP - Purchase$2.38+10,00010,000New+$23,825
D
2020-07-21
ONCTAker Hazel MLegal CounselP - Purchase$2.38+41,97251,271+451%+$99,998
D
2020-07-21
ONCTShanghai Pharmaceutical (Usa) Inc.10%P - Purchase$2.38+1,049,3173,544,431+42%+$2,499,998
D
2020-05-21
ONCTHale David FDirP - Purchase$0.00+17,412735,164+2%+$0
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top